Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AMPA receptor binding described for Lilly's LY-395153

Aug. 21, 2001

Merck & Co. describes novel derivatives as selective ligands for GABA-A receptors

Aug. 20, 2001

Venlafaxine ER shows good long-term results in GAD patients

Aug. 14, 2001

Neuroprotective activity of estrogens and SERMs examined at congress

Aug. 14, 2001

Copaxone approved by 15 European countries for the treatment of MS

Aug. 13, 2001

Transtec receives marketing approval in Germany for the treatment of nonacute pain

Aug. 13, 2001

Taisho identifies PGD2-like agonists potentially useful for cardiovascular disorders

Aug. 13, 2001

New cathepsin and calpain inhibitors and their use described by Senju

Aug. 10, 2001

Antalarmin inhibits stress-induced gastric ulceration in rats

Aug. 10, 2001

Genetically modified neural stem cells may be useful in the treatment of PD

Aug. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...